Posted On: 01/28/2016 4:32:54 PM
Post# of 72447
You beat me to it... But I added a little more from the article.. Great stuff!!!
TLSR: As far as your milestones for 2016 are concerned, you are moving ahead with your Phase 3 ABSSSI trial with brilacidin as well, correct?
LE: Yes, it is at the top of our list of goals for 2016. In addition to the ovarian cancer study with Kevetrin and the ABSSSI Phase 3 with brilacidin, we also plan on starting a brilacidin trial for ulcerative proctitis in March. That represents another use of this product, as an anti-inflammatory. We are also presently in a Phase 2 trial for oral mucositis with brilacidin under an FDA fast track designation, and we would hope to get interim data for that in the upcoming months.
TLSR: As far as your milestones for 2016 are concerned, you are moving ahead with your Phase 3 ABSSSI trial with brilacidin as well, correct?
LE: Yes, it is at the top of our list of goals for 2016. In addition to the ovarian cancer study with Kevetrin and the ABSSSI Phase 3 with brilacidin, we also plan on starting a brilacidin trial for ulcerative proctitis in March. That represents another use of this product, as an anti-inflammatory. We are also presently in a Phase 2 trial for oral mucositis with brilacidin under an FDA fast track designation, and we would hope to get interim data for that in the upcoming months.
(0)
(0)
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
